- Home
- BTMD
BTMD
Biote Corp.
as 11-21-2024 2:32pm EST
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations.
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | IRVING |
| Market Cap: | 224.1M | IPO Year: | N/A |
| Target Price: | $8.39 | AVG Volume (30 days): | 168.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.21 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.65 - $8.44 | Next Earning Date: | 11-12-2024 |
| Revenue: | $193,060,000 | Revenue Growth: | 4.84% |
| Revenue Growth (this year): | 11.06% | Revenue Growth (next year): | 14.82% |
Latest Biote Corp. News
BTMD Breaking Stock News: Dive into BTMD Ticker-Specific Updates for Smart Investing
GuruFocus.com
3 days ago
Biote Corp (BTMD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Enhancements
Zacks
3 days ago
Wall Street Analysts Predict a 76.99% Upside in biote Corp. (BTMD): Here's What You Should Know
Zacks
8 days ago
Is biote Corp. (BTMD) Stock Undervalued Right Now?
Zacks
9 days ago
Biote Corp. (BTMD) Beats Q3 Earnings Estimates
Business Wire
9 days ago
Biote Reports Third Quarter 2024 Financial Results
GuruFocus.com
10 days ago
Biote Corp (BTMD) Q3 2024: Everything You Need To Know Ahead Of Earnings
Zacks
20 days ago
Wall Street Analysts See an 88.04% Upside in biote Corp. (BTMD): Can the Stock Really Move This High?
Business Wire
23 days ago
Biote Schedules Third Quarter 2024 Financial Results Release and Conference Call
Compare BTMD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BTMD Biote Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.